Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
Quinine
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/09/2021
Niclosamide
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/07/2021
Clofazimine
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/07/2021
Salinomycin
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/07/2021
Arbidol
Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/03/2021
Grazoprevir
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/31/2021
Topotecan
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/30/2021
Itolizumab
Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/29/2021
Amantadine
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/27/2021
Velpatasvir
Potential treatment - theoretical effect Used to treat other disease Antiviral Mar/26/2021
Temsirolimus
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/25/2021
Everolimus
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/25/2021
Rapamycin
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/25/2021
Azoximer bromide
Potential treatment - clinical evidence Used to treat other disease Other treatment Mar/25/2021
Ribavirin
Recommended by China's NHC Guidelines Used to treat other disease Antiviral Mar/25/2021
Levamisole
Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/24/2021
Cepharanthine
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/23/2021
Plerixafor
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/23/2021
Floxuridine
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/23/2021
Spectinomycin
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/23/2021